Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure.

[1]  I. Kubota,et al.  Angiotensin‐converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure , 2003, Nuclear medicine communications.

[2]  T. Takano,et al.  Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. , 2002, The American journal of medicine.

[3]  K. Kawamura,et al.  Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB , 2000, Clinical chemistry and laboratory medicine.

[4]  H. Kishida,et al.  Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. , 1999, The American journal of cardiology.

[5]  J. Mcwhir,et al.  Requirement for the heart‐type fatty acid binding protein in cardiac fatty acid utilization , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  F. Recchia,et al.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.

[7]  M. Simoons,et al.  Fatty acid-binding protein and the early detection of acute myocardial infarction. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[8]  B. Pau,et al.  Circulating cardiac troponin I in severe congestive heart failure. , 1997, Circulation.

[9]  Youkou Tominaga,et al.  Use of serum creatine kinase MM isoforms for predicting the progression of left ventricular dilation in patients with hypertrophic cardiomyopathy. , 1997, Japanese circulation journal.

[10]  D. Kelly,et al.  Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.

[11]  W. Hermens,et al.  Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. , 1994, British heart journal.

[12]  J. Glatz,et al.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man , 1992, Molecular and Cellular Biochemistry.

[13]  Y. Hirota,et al.  Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. , 1991, Clinical biochemistry.

[14]  M. Mayr,et al.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.

[15]  D. Kelly,et al.  The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). , 1998, International journal of molecular medicine.